GAS5 is downregulated in gastric cancer cells by promoter hypermethylation and regulates Adriamycin sensitivity

European Review for Medical and Pharmacological Sciences

Volumn 20, Issue 15, 2016, Pages 3199-3205

  Zhang, N ^a   Wang, A Y ^b   Wang, X K ^c   Sun, X M ^d   Xue, H Z ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b Shouguang People's Hospital   (China)

^c Department of Respiratory Medicine   (China)

^d Affiliated Hospital of Weifang   (China)

Author keywords

Adriamycin; GAS5; Gastric cancer; Methylation

Indexed keywords

DECITABINE; DOXORUBICIN; GROWTH ARREST SPECIFIC TRANSCRIPT 5; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CHEMOSENSITIVITY; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GASTRIC CANCER CELL LINE; GENE OVEREXPRESSION; GENETIC REGULATION; GENETIC TRANSFECTION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; PHARMACOGENETICS; PROMOTER REGION; SENSITIVITY ANALYSIS; SGC-7901 CELL LINE; STOMACH CANCER; STOMACH TISSUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA METHYLATION; DOWN-REGULATION; DOXORUBICIN; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 85017163620     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. SIEGEL R, MA J, ZOU Z, JEMAL A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. DONG CX, FU JF, YE XY, LI XF, ZHONG X, YUAN Y. Surgical resection of advanced gastric cancer following trastuzumab/oxaliplatin/capecitabine combination therapy. World J Gastroenterol 2014;20:12355-12358.
3. WANG LL, ZHANG XH, ZHANG X, CHU JK. MiR-30a increases cisplatin sensitivity of gastric cancer cells through suppressing epithelial-tomesenchymal transition (EMT). Eur Rev Med Pharmacol Sci 2016;20:1733-1739.
4. WANG Y, WU K, YANG Z, ZHAO Q, FAN D, XU P, NIE Y, FAN D. Multidrug-resistance related long non-coding RNA expression profile analysis of gastric cancer. PLoS One 2015;10:e0135461.
5. WANG Y, ZHANG D, WU K, ZHAO Q, NIE Y, FAN D. Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines. Mol Cell Biol 2014;34:3182-3193.
6. MA C, SHI X, ZHU Q, LI Q, LIU Y, YAO Y, SONG Y. The growth arrest-specific transcript 5 (GAS5): a pivotal tumor suppressor long noncoding RNA in human cancers. Tumour Biol 2016;37:1437-1444.
7. SUN M, JIN FY, XIA R, KONG R, LI JH, XU TP, LIU YW, ZHANG EB, LIU XH, DE W. Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer. BMC Cancer 2014;14:319.
8. GUO X, DENG K, WANG H, XIA J, SHAN T, LIANG Z, YAO L, JIN S. GAS5 inhibits gastric cancer cell proliferation partly by modulating CDK6. Oncol Res Treat 2015;38:362-366.
9. LIU Y, ZHAO J, ZHANG W, GAN J, HU C, HUANG G, ZHANG Y. lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer. Sci Rep 2015;5:10159.
10. SHI X, SUN M, LIU H, YAO Y, KONG R, CHEN F, SONG Y. A critical role for the long non-coding RNA GAS5 in proliferation and apoptosis in non-small-cell lung cancer. Mol Carcinog 2015;54 Suppl 1:E1-E12.
11. ZOU Y, LING YH, SIRONI J, SCHWARTZ EL, PEREZ-SOLER R, PIPERDI B. The autophagy inhibitor chloroquine overcomes the innate resistance of wild-type EGFR non-small-cell lung cancer cells to erlotinib. J Thorac Oncol 2013;8:693-702.
12. PICKARD MR, WILLIAMS GT. Regulation of apoptosis by long non-coding RNA GAS5 in breast cancer cells: implications for chemotherapy. Breast Cancer Res Treat 2014;145:359-370.
13. YACQUB-USMAN K, PICKARD MR, WILLIAMS GT. Reciprocal regulation of GAS5 lncRNA levels and mTOR inhibitor action in prostate cancer cells. Prostate 2015;75:693-705.
14. ALBERTI C. Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications. Eur Rev Med Pharmacol Sci 2016;20:1001-1002.
15. LIU Q, SUN S, YU W, JIANG J, ZHUO F, QIU G, XU S, JIANG X. Altered expression of long non-coding RNAs during genotoxic stress-induced cell death in human glioma cells. J Neurooncol 2015;122:283-292.
16. KRELL J, FRAMPTON AE, MIRNEZAMI R, HARDING V, DE GIORGIO A, ROCA ALONSO L, COHEN P, OTTAVIANI S, COLOMBO T, JACOB J, PELLEGRINO L, BUCHANAN G, STEBBING J, CASTELLANO L. Growth arrest-specific transcript 5 associated snoRNA levels are related to p53 expression and DNA damage in colorectal cancer. PLoS One 2014;9:e98561.
17. TRAVERSO N, RICCIARELLI R, NITTI M, MARENGO B, FURFARO AL, PRONZATO MA, MARINARI UM, DOMENICOTTI C. Role of glutathione in cancer progression and chemoresistance. Oxid Med Cell Longev 2013;2013:972913.
18. MA GF, ZHANG RF, YING KJ, WANG D. Effect evaluation of cisplatin-gemcitabine combination chemotherapy for advanced non-small cell lung cancer patients using microarray data. Eur Rev Med Pharmacol Sci 2015;19:578-585.
19. YU X, LI Z. Long non-coding RNA growth arrestspecific transcript 5 in tumor biology. Oncol Lett 2015;10:1953-1958.
20. MOURTADA-MAARABOUNI M, PICKARD MR, HEDGE VL, FARZANEH F, WILLIAMS GT. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 2009;28:195-208.
21. PICKARD MR, MOURTADA-MAARABOUNI M, WILLIAMS GT. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim Biophys Acta 2013;1832:1613-1623.
22. TESCHENDORFF AE, LEE SH, JONES A, FIEGL H, KALWA M, WAGNER W, CHINDERA K, EVANS I, DUBEAU L, ORJALO A, HORLINGS HM, NIEDERREITER L, KASER A, YANG W, GOODE EL, FRIDLEY BL, JENNER RG, BERNS EM, WIK E, SALVESEN HB, WISMAN GB, VAN DER ZEE AG, DAVIDSON B, TROPE CG, LAMBRECHTS S, VERGOTE I, CALVERT H, JACOBS IJ, WIDSCHWENDTER M. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med 2015;7:108.
23. MA Y, YANG Y, WANG F, MOYER MP, WEI Q, ZHANG P, YANG Z, LIU W, ZHANG H, CHEN N, WANG H, WANG H, QIN H. Long non-coding RNA CCAL regulates colorectal cancer progression by activating Wnt/beta-catenin signalling pathway via suppression of activator protein 2alpha. Gut 2015 May 20. pii: gutjnl-2014-308392. doi: 10.1136/gutjnl-2014-308392. [Epub ahead of print].
24. DONG S, QU X, LI W, ZHONG X, LI P, YANG S, CHEN X, SHAO M, ZHANG L. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. J Hematol Oncol 2015;8:43.